-
公开(公告)号:US20170258841A1
公开(公告)日:2017-09-14
申请号:US15448050
申请日:2017-03-02
Inventor: Tsung-Ming LEE , Ming-Hsi CHUANG , Chun-Hung CHEN , Po-Cheng LIN , Chia-Hsin Lee
IPC: A61K35/28 , A61K9/00 , A61K31/5377 , A61K33/00 , A61K31/404
CPC classification number: A61K35/28 , A61K9/0019 , A61K31/404 , A61K31/5377 , A61K33/00 , A61K2300/00
Abstract: This invention provides a pharmaceutical compositions for treating arrhythmia. The pharmaceutical compositions comprise stem cells, pretreated with n-butylidenephthalide (BP).
-
公开(公告)号:US20150274769A1
公开(公告)日:2015-10-01
申请号:US14300623
申请日:2014-06-10
Inventor: Zer-Ran YU , Be-Jen WANG , Shu-Mei LIN , Hua-Ching LIN , Ming-Hsi CHUANG , Chu-Ting LIU , Chiu-Ying PENG , Lin-Hsiang CHUANG
IPC: C07J1/00
CPC classification number: C07J1/007 , A61K35/50 , C07J1/0055 , Y02P20/544
Abstract: The present invention provides a method of separating estrogen from placenta, which uses supercritical fluid technique to load the placenta powder of human body or sheep, pig, deer and other animals into an extraction tank. Under the operating conditions of preset pressure and temperature, supercritical solvent is added into the extraction tank to extract estrogen from placenta, so as to acquire de-estrogen placenta powder and placenta extract liquor. Under the same condition, the de-estrogen placenta extract liquor and supercritical solvent are added by a preset volume flow ratio into an adsorption tank. The estrogen in the placenta extract liquor is adsorbed by the adsorption tank to obtain de-estrogen placenta extract. It is then eluted with ethanol solution by gradient proportion to obtain purified natural estrogen.
Abstract translation: 本发明提供了从胎盘分离雌激素的方法,其使用超临界流体技术将人体胎盘粉或绵羊,猪,鹿等动物加载到提取罐中。 在预设压力和温度的操作条件下,将超临界溶剂加入提取罐中,从胎盘中提取雌激素,以获得雌激素胎盘粉和胎盘提取液。 在相同的条件下,将去雌激素胎盘提取液和超临界溶剂以预设的体积流量比添加到吸附罐中。 胎盘提取液中的雌激素被吸附槽吸附,得到雌激素胎盘提取物。 然后用乙醇溶液以梯度比例洗脱,得到纯化的天然雌激素。
-
公开(公告)号:US20170296586A1
公开(公告)日:2017-10-19
申请号:US15478698
申请日:2017-04-04
Inventor: Sheng-Tzung TSAI , Ming-Hsi CHUANG , Po-Cheng LIN , Pi-Chun HUANG
IPC: A61K35/28
CPC classification number: A61K35/28
Abstract: The present invention provides a pharmaceutical composition to treat cerebral atrophy associated disease. Said pharmaceutical composition comprising adipose-derived stem cells, can reverse the function of excitatory synapses in dementia patients and improve the function of memory storage area in brain.
-
-